Suppr超能文献

腹腔镜及机器人辅助手术治疗脾动脉瘤:一项系统评价

Laparoscopic and Robotic Surgery for Splenic Artery Aneurysm: A Systematic Review.

作者信息

Ossola Paolo, Mascioli Federico, Coletta Diego

机构信息

Pietro Valdoni, Department of Surgery, Sapienza University of Rome, Rome, Italy.

Pietro Valdoni, Department of Surgery, Sapienza University of Rome, Rome, Italy.

出版信息

Ann Vasc Surg. 2020 Oct;68:527-535. doi: 10.1016/j.avsg.2020.05.037. Epub 2020 May 29.

Abstract

BACKGROUND

Splenic artery aneurysms (SAAs) are the most frequent visceral aneurysms, with a life-threatening risk in case of rupture. Our systematic review investigated the features of minimally invasive surgical approaches in vascular surgery for SAAs: robotic surgery and laparoscopy.

METHODS

PubMed, EMBASE, and the Web of Science were systematically searched for robotic or laparoscopic surgery reports in SAA up to January 2020. The outcomes of the study were operative time, overall morbidity, intraoperative and postoperative complications, conversion rate, and length of hospital stay.

RESULTS

A total of 40 studies (29 case reports, 8 case series, 1 randomized trial, 1 video, and 1 image), including 107 patients, were considered eligible for the review. Mean operative time was 164.2 ± 75.9 min (laparoscopy), 165 min (±75.6 min) and 150 min (±87.7 min) for robotic procedures. Four cases of conversion (4.8% of all laparoscopic procedures) were reported; no conversion in the robotic series was reported. Overall morbidity was 11.2%; the most common complications were postoperative spleen infarction and pancreatitis. Medium estimated blood loss was 105.2 mL (±239.5 mL) (robotic 186.6 (±202.4) mL, laparoscopic 63 (0-270) mL). Overall length of stay was 5.43 (±5.5) days (robotic 6.1 days and laparoscopic 5.5 days). Neither mortality nor reinterventions were observed in robotic and laparoscopic series.

CONCLUSIONS

In accordance with the available literature, laparoscopy and robotic surgery represent, in selected cases, a valid choice to treat SAAs. Multidisciplinary teams, comprehensive of vascular and general surgeons skilled in robotic and laparoscopic procedures, could permit to offer a tailored treatment for each patient. The rarity of this disease does not allow to perform randomized controlled trials; thus the possibility to reach definitive conclusions is currently precluded.

摘要

背景

脾动脉瘤(SAA)是最常见的内脏动脉瘤,破裂时具有危及生命的风险。我们的系统评价研究了血管外科中SAA微创外科手术方法的特点:机器人手术和腹腔镜手术。

方法

系统检索了截至2020年1月PubMed、EMBASE和Web of Science上关于SAA机器人或腹腔镜手术的报告。研究结果包括手术时间、总体发病率、术中及术后并发症、中转率和住院时间。

结果

共纳入40项研究(29例病例报告、8例病例系列、1项随机试验、1个视频和1张图像),涉及107例患者,符合纳入综述的标准。腹腔镜手术的平均手术时间为164.2±75.9分钟,机器人手术的平均手术时间为165分钟(±75.6分钟)和150分钟(±87.7分钟)。报告了4例中转病例(占所有腹腔镜手术的4.8%);机器人手术系列未报告中转病例。总体发病率为11.2%;最常见的并发症是术后脾梗死和胰腺炎。估计平均失血量为105.2毫升(±239.5毫升)(机器人手术186.6(±202.4)毫升,腹腔镜手术63(0 - 270)毫升)。总体住院时间为5.43(±5.5)天(机器人手术6.1天,腹腔镜手术5.5天)。机器人手术和腹腔镜手术系列均未观察到死亡或再次干预情况。

结论

根据现有文献,在某些情况下,腹腔镜手术和机器人手术是治疗SAA的有效选择。由精通机器人和腹腔镜手术的血管外科医生及普通外科医生组成的多学科团队,可以为每位患者提供量身定制的治疗方案。这种疾病的罕见性使得无法进行随机对照试验;因此,目前无法得出明确结论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验